Shares of Cambridge, MA-based Epizyme jumped 10% this morning after the company announced that it had won a $4 million payment from GSK ($GSK) after hitting the third of the three histone methyltransferase targets in their collaboration. Release
Shares of Cambridge, MA-based Epizyme jumped 10% this morning after the company announced that it had won a $4 million payment from GSK ($GSK) after hitting the third of the three histone methyltransferase targets in their collaboration. Release